Arcutis Biotherapeutics Logo

Arcutis Biotherapeutics

🇺🇸
ARQT
US03969K1088

Arcutis Biotherapeutics is a U.S.-based biotech company specializing in the development of innovative dermatological therapies. Through cutting-edge research, Arcutis addresses immune-mediated skin diseases, aiming to provide highly effective treatment options for patients.

Next Quarterly Earnings

Thursday, October 29, 2026
CW 44
After-Hours
In 63 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 1, 2026

Stock Price

Frequently asked questions

When will Arcutis Biotherapeutics report its next quarterly earnings?

Arcutis Biotherapeutics is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Arcutis Biotherapeutics last report quarterly earnings?

Arcutis Biotherapeutics last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 0.11 USD.

How often has Arcutis Biotherapeutics beaten expectations?

Arcutis Biotherapeutics has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).

How do I add the Arcutis Biotherapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$0.09
Actual:
Q2 2026
Beat
Estimate:$0.05
Actual:$0.11
Difference:+$0.06
Q1 2026
Missed
Estimate:-$0.04
Actual:-$0.09
Difference:-$0.05
Price reaction (1 day):-14.5 %
Price reaction (7 days):-10.3 %
Q4 2025
Beat
Estimate:$0.09
Actual:$0.13
Difference:+$0.04
Price reaction (1 day):+5.8 %
Price reaction (7 days):-10.7 %
Q2 2025
Beat
Estimate:-$0.09
Actual:$0.06
Difference:+$0.15
Q1 2025
Beat
Estimate:-$0.16
Actual:-$0.13
Difference:+$0.03

Earnings statistics

Estimates vs. results

4/5
Quarters above estimates
80%
Beat rate
+6.6%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Arcutis Biotherapeutics
Ticker Symbol
ARQT
ISIN
US03969K1088
Country
🇺🇸
USA
Sector